Differences in the lipoprotein distribution of halofantrine are regulated by lipoprotein apolar lipid and protein concentration and lipid transfer protein I activity: In vitro studies in normolipidemic and dyslipidemic human plasmas

Journal of Pharmaceutical Sciences

Volumn 88, Issue 2, 1999, Pages 185-190

  Wasan, Kishor M ^a   Ramaswamy, Manisha ^a   McIntosh, Michelle P ^b   Porter, Christopher J H ^b   Charman, William N ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER; HALOFANTRINE; HIGH DENSITY LIPOPROTEIN; LIPID TRANSFER PROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ARTICLE; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; DRUG DISTRIBUTION; DYSLIPIDEMIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERLIPIDEMIA; HYPOLIPEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; PLASMA;

EID: 0033010386     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js980353k     Document Type: Article

References (22)

1. Davis, R. A.; Vance, J. E. Structure, assembly and secretion of lipoproteins. In Biochemistry of lipids, lipoproteins and membranes; Vance, D. E.; Vance, J. E., Eds.; Elsevier: New York, 1996; pp 473-493.
2. Wasan, K. M.; Vadiei, K.; Lopez-Berestein, G.; Luke, D. R. Pharmacokinetics, tissue distribution, and toxicity of free and liposomal amphotericin B. J. Infect. Dis. 1990, 161, 562-566.
3. Wasan, K. M.; Grossie, Jr., V. B.; Lopez-Berestein, G. Concentrations in serum and tissue distribution of free and liposomal amphotericin B in rats on continuous Intralipid infusion. Antimicrob. Agents Chemother. 1994, 38, 2224-2226.
4. Le Maire, M.; Tillement, J. P. Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood. J. Pharm. Pharmacol. 1982, 34, 715-718.
5. Wasan, K. M.; Morton, R. E. Differences in lipoprotein concentration and composition modify the plasma distribution of free and liposomal annamycin. Pharm. Res. 1996, 13, 462-468.
6. Wasan, K. M.; Perez-Soler, P. Distribution of free and liposomal annamycin within human plasma is regulated by plasma triglyceride concentrations but not by lipid transfer protein. J. Pharm. Sci. 1995, 84, 1094-1100.
7. Wasan, K. M.; Pritchard, P. H.; Ramaswamy, M.; Wong, W.; Donnachie, E. M.; Brunner, L. J. Differences in lipoprotein lipid concentration and composition modify the plasma distribution of cyclosporine. Pharm. Res. 1997, 14, 1613-1620.
8. Cenni, B.; Meyer, J.; Brandt, R.; Betschart, B. The antimalarial drug halofantrine is bound mainly to low and high-density lipoproteins in human serum. Br. J. Clin. Pharmacol. 1995, 39, 519-526.
9. McIntosh, M. P.; Porter, C. J. H.; Wasan, K. M.; Ramaswamy, M.; Charman. W. N. Differences in the lipoprotein binding profile of halofantrine in fed and fasted human or beagle plasma are dictated by the respective masses of core apolar lipoprotein lipid. J. Pharm. Sci., in press.
10. Humberstone, A. J.; Porter, C. J. H.; Edwards, G.; Charman, W. N. Distribution of halofantrine between plasma lipoprotein fractions after IV administration to pre- and post-prandial beagle dogs. Pharm. Res. 1995, 12, S-356 (abstract).
11. 50 of halofantrine against Plasmodium falciparum. J. Pharm. Sci. 1998, 87, 256-258.
12. Morton, R. E.; Zilversmit, D. B. Purification and characterization of lipid transfer protein(s) from human lipoprotein-deficient plasma. J. Lipid Res. 1982, 23, 1058-1067.
13. Wasan, K. M.; Morton, R. E.; Rosenblum, M. G.; Lopez-Berestein, G. Decreased toxicity of liposomal amphotericin B due to association of amphotericin B with high-density lipoproteins: Role of lipid transfer protein. J. Pharm. Sci. 1994, 83, 1006-1010.
14. Wasan, K. M.; Ramaswamy, M.; Wong, W.; Pritchard, P. H. Lipid transfer protein I facilitated transfer of cyclosporine from low- to high-density lipoproteins is only partially dependent on its cholesteryl ester transfer activity. J. Pharmacol. Exp. Ther. 1998, 284, 509-605.
15. Havel, R. J.; Eder, H. A.; Bragdon, J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 1955, 34, 1345-1353.
16. Ramaswamy, M.; Zhang, X.; Burt, H. M.; Wasan, K. M. The human plasma distribution of free paclitaxel and paclitaxel associated with diblock copolymers. J. Pharm. Sci. 1997, 86, 460-464.
17. Burstein, M.; Scholnick, H. R.; Morfin, R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J. Lipid Res. 1970, 11, 583-595.
18. Wasan, K. M.; Ramaswamy, M.; Haley, J.; Dunn, B. P. Administration of long-term tamoxifen therapy modifies the plasma lipoprotein-lipid concentration and lipid transfer protein I activity in postmenopausal women with breast cancer. J. Pharm. Sci. 1997, 86, 876-879.
19. Pattnaik, N. M.; Zilversmit, D. B. Interaction of cholesteryl ester exchange protein with human plasma lipoproteins and phospholipid vesicles. J. Biol. Chem. 1979, 254, 2782-2786.
20. Humberstone, A. J.; Currie, G. J.; Porter, C. J. H.; Scanlon, M. J.; Charman, W. N. A simplified liquid chromatography assay for the quantitation of halofantrine and desbutylhalofantrine in plasma and identification of a degradation product of desbutylhalofantrine formed under alkaline conditions. J. Pharm. Biomed. Anal. 1995, 13, 265-272.
21. Karbwang, J.; Na Bangchang, K. Clinical pharmacokinetics of halofantrine. Clin. Pharmacokinet. 1994, 27, 104-119.
22. Monlun, E.; Le Metayer, P.; Szwandt, S.; Neau, D.; Longy Boursier, M.; Horton, J.; Le Bras, M. Cardiac complications of halofantrine: a prospective study of 20 patients. Trans. Roy Soc. Trop. Med. Hyg. 1995, 89, 430-433.